Picture BIO Deutschland European Business Development Conference 600x60px
Document › Details

Proteros Biostructures GmbH. (2/9/12). "Press Release: Proteros Announces the Appointment of Dr. Klaus Hinterding as Chief Scientific Officer and Member of the Management Board". Martinsried.

Region Region Martinsried
  Country Germany
Organisations Organisation Proteros Biostructures GmbH
  Group Proteros (Group)
  Organisation 2 Roche (Group)
Products Product drug discovery services
  Product 2 Gilenya®
Persons Person Hinterding, Klaus (Proteros 201202– CSO before Roche + Novartis)
  Person 2 Neuefeind, Torsten (Proteros Biostructures 200610 Managing Director)

Proteros biostructures GmbH (Proteros) announced today that Dr. Klaus Hinterding, formerly at Hoffmann-La Roche Ltd. (Roche), has joined the company as Chief Scientific Officer and member of the management board. Dr. Hinterding brings to Proteros considerable pharmaceutical industry experience that spans early research through to clinical development in various therapeutic areas.

At Novartis, his research contributed to the understanding of the mode-of-action of GilenyaTM, licensed for the treatment of multiple sclerosis, and he led the team that discovered a selective S1P-receptor agonist, currently in Phase II for the same indication. As Life Cycle Leader at Roche he implemented an innovative development and commercial strategy for one of Roche´s leading late-stage development candidates that culminated in a multi-thousand patient clinical program in cardiovascular disease. Dr. Hinterding has led various international research & development collaborations and is an author and inventor of more than 20 patents and publications. He was a post-doctoral fellow at Harvard University and received his PhD in organic Chemistry from the University of Karlsruhe.

Torsten Neuefeind, founder and CEO of Proteros, said: "Klaus's significant background in medicinal chemistry, drug discovery and clinical development will have an immediate impact on Proteros' growing integrated lead discovery business. Klaus will be responsible for growing the organization that supports our clients as they rely on Proteros to deliver analytical services of crystallography, compound profiling, proteins and increasingly lead compounds, through innovative, integrated structure guided drug discovery collaborations. We welcome Klaus to Proteros."

About Proteros biostructures GmbH:

Proteros is a privately held company that provides services and proprietary technologies to support integrated drug discovery. Proteros uses its technical expertise, industrial processes and unique technologies for crystallography, kinetic and thermodynamic profiling and fragment-based lead generation incorporating protein structure inspired compound and fragment libraries. The platform enables "knowledge driven lead engineering" to accelerate and improve protein structure analysis and structure-based drug discovery. Proteros complements its clients's internal capabilities with external expertise and access to flexible resources. Proteros currently provides services to more than 80 pharmaceutical and biotechnology clients in North America, Europe and Asia. Proteros US, Inc. is a wholly owned subsidiary of Proteros established to serve the growing customer base in North America.

For further information please visit the website at:

Proteros biostructures GmbH
Thomas Waldmann, Ph.D.
Bunsenstrasse 7a
D-82152, Martinsried
Phone: +49 89 7007 61 - 0

Record changed: 2014-04-23


Picture BioM Munich Biomarker Conference 2015 München Germany December 600x60px

More documents for Proteros (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture LSBC Central European Life Science Investment Conference 2015 600x60px

» top


Banner C5 Communications Life Sciences IP Summit 2015 Berlin 120x180px Picture IQPC IP Life Sciences Exchange 2015 Frankfurt Germany 120x180px Picture EBD Group BIO Europe 2015 BEU Munich November 120x80px Picture BIO Deutschland European Business Development Conference 120x240px Picture Universal Medica Innovations Days 2015 Paris France October 120x180px Picture LSBC Central European Life Science Investment Conference 2015 120x240px Picture YIP Events China Bio-Pharma Executive Summit Nov 2015 Shanghai 120x180px Picture BioM Munich Biomarker Conference 2015 München Germany December 120x180px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px